Rhabdomyosarcoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Clinical Trials

A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma
Conditions:   Alveolar Rhabdomyosarcoma;   Botryoid-Type Embryonal Rhabdomyosarcoma;   Embryonal Rhabdomyosarcoma;   Rhabdomyosarcoma;   Solid Alveolar Rhabdomyosarcoma;   Spindle Cell Rhabdomyosarcoma;   Spindle Cell/Sclerosing Rhabdomyosarcoma Interventions:   Drug: Cyclophosphamide;   Biological: Dactinomycin;   Radiation: Radiation Therapy;   Drug: Vincristine Sulfate;   Drug: Vinorelbine Tartrate Sponsor:   Children's Oncology Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 6, 2021 Category: Research Source Type: clinical trials